Patent · US Active

Pharmaceutical preparation stably comprising CD147 monoclonal antibody

US11027016B2 · kind B2 · utility

0Cited by

2References

4Claims

0Family size

Assignee

Xiaochun Chen · CN

Inventors

Hao Tang · Lexington, US
Qiang Feng · Qingdao, CN
Tianyi Yang · Yokohama, JP
Mingxi Chen · Changzhou City, CN

Key dates

Filing date	Dec 27, 2017
Grant date	Jun 8, 2021
Priority date	—
Expiry date	Dec 27, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed is a pharmaceutical preparation comprising a CD147 monoclonal antibody, a buffer, a protein protectant and a surfactant. The pharmaceutical preparation can maintain the stability of the CD147 monoclonal antibody over a long period of time. Also disclosed are the use of the pharmaceutical preparation in the preparation of a drug for treating CD147-related diseases, in particular non-small cell lung cancer, and a method for preparing the pharmaceutical preparation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.